Dr. John Campbell

UK to stop primary covid vaccine course https://twitter.com/DHSCgovuk https://twitter.com/UKHSA Getting a 1st and 2nd dose of the COVID-19 vaccine https://www.nhs.uk/conditions/covid-19/covid-19-vaccination/getting-a-1st-and-2nd-dose-of-the-covid-19-vaccine/ Currently, 75 + or comorbidities CDC advice as today https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect.html J and J in the US About 19 million people More than 31.5 million doses December 2021 (UK) https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement-7-may-2021/use-of-the-astrazeneca-covid-19-azd1222-vaccine-updated-jcvi-statement-7-may-2021 https://www.express.co.uk/news/uk/1540424/astrazeneca-vaccine-not-used-booster-what-happened-oxford-mRNA-evg A spokesperson JCVI The results of the COV-BOOST trial conducted during the summer of 2021 provided good evidence that mRNA vaccines are the most effective option for the UK’s booster programme. (Denmark stopped AZ in April 2021) Patients launch legal action against AstraZeneca over its covid-19 vaccine (BMJ) https://www.bmj.com/content/380/bmj.p725 AZ been sent pre-action protocol letters First step in a legal claim, 75 claimants Some have survived with catastrophic injuries following blood clots. Relatives representing others who suffered adverse reactions. Consumer Protection Act 1987 Must show that the vaccine was not as safe as the public were entitled to expect Vaccine Damage Payment Scheme Limited to £120 000 per claim, applicants must prove severe disablement Administrative staff, four to 80 Freedom of information request NHS Business Services, by 6 March 2023 Scheme had received 4,017 claims 622 concerned AstraZeneca vaccine 348 the Pfizer 43 the Moderna vaccine 334 were for a severe adverse reaction, (claims by relatives) Australia https://www.youtube.com/watch?v=2i8Jxciomzc&t=34s Population, 26 million 3,374 claims

Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins https://www.niaid.nih.gov/news-events/clinical-trial-mrna-universal-influenza-vaccine-candidate-begins https://clinicaltrials.gov/ct2/show/NCT05755620 Clinical trial, experimental universal influenza vaccine National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), (part of National Institutes of Health) Enrolling volunteers, Duke University, Durham, North Carolina Phase 1 trial H1ssF-3928 mRNA-LNP, for safety and ability to induce an immune response. N = up to 50 healthy volunteers, (18 through 49) Three groups of 10 participants each 10, 25 and 50 micrograms After evaluation of the data to determine an optimum dosage, an additional 10 to receive the optimum dosage Study include a group, receive a current quadrivalent. Comparison between “immunogenicity and safety” Follow-up appointments for up to one year Annual seasonal flu vaccines Valuable tools in controlling the spread and severity of influenza Do not provide immunity against every flu strain. Each year is based on prediction Vaccine manufacturers then need time (dominant strains of the virus can change) An effective universal flu vaccine Acting NIAID Director Hugh Auchincloss Protecting its recipients against a wide variety of strains, ideally providing durable long-term immunity. “A universal influenza vaccine would be a major public health achievement and could eliminate the need for both annual development of seasonal influenza vaccines, as well as the need for patients to get a flu shot each year” Defence against the spread of a future flu pandemic. Both vaccines use a specific portion of a flu protein, Hemagglutinin (HA) stern (not head) flu protein UK cements 10-year-partnership with Moderna in major boost for vaccines and research https://www.gov.uk/government/news/uk-cements-10-year-partnership-with-moderna-in-major-boost-for-vaccines-and-research to produce up to 250 million vaccines per year https://www.theguardian.com/business/2022/jun/22/moderna-build-uk-mrna-vaccine-research-manufacturing-centre-covid £1bn deal with the UK government UK government has committed to buying Moderna’s vaccines for the next decade. Harwell, Oxfordshire https://www.bbc.co.uk/news/uk-england-oxfordshire-64856379 Innovation and Technology Centre built by the 2025 Moderna provide the UK public with access to mRNA vaccines for a wide range of respiratory diseases Questions Control of antigen dose? How long antigen will be produced for? Degree of systemic distribution? Degree of systemic inflammation?

Covid symptoms are mostly ‘cold like’ and mild Symptom Prevalence (%) Sore throat 60.45 Blocked nose 57.17 Runny nose 52.68 Headache 49.74 Sneezing 49.05 Cough no phlegm 46.46 Hoarse voice 40.24 Cough with phlegm 40.24 Muscle pains aches 30.57 Fatigue 23.66 Dizzy light headed 21.07 Altered smell 20.38 Eye soreness 18.83 Swollen neck glands 18.65 Loss of smell 17.27 Shortness of breath 14.51 Earache 13.99 Joint pain shoulders 13.99 Fever 13.47 Chest pain tightness 13.3 UK excess deaths https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths Week 16 (W/E 21 April) + 22.1% 2,540 Week 17 (W/E 28 April) + 12.9% 1,569 Week 18 (W/E 5 May) + 5.4% 598 Professor Fenton. Substack, https://wherearethenumbers.substack.com/about And YouTube, https://www.youtube.com/@NormanFenton81/videos Canada excess deaths https://www150.statcan.gc.ca/n1/pub/71-607-x/71-607-x2021028-eng.htm The actual number of observed deaths is ‘at least’ the black dotted line. Whenever the black line is above the blue line it is probable that there were excess deaths Whenever the black line is above the red dotted line it is almost certain there are excess deaths. So, it is likely there have been excess deaths every month since mid-March with especially large peaks in April-May and December. Any number bigger than the red dotted line, then we expect something new is likely causing this especially high number of deaths. Australia excess deaths https://www.abs.gov.au/statistics/health/causes-death/provisional-mortality-statistics/jan-2023 January 2023 There were 14,547 deaths in January, 12.4% more than the baseline average (but 10.5% less than January 2022) COVID-19 caused 213 deaths in February, down from 731 in January Jan to December 2022 In 2022, there were 190,394 deaths, which is 25,235 (15.3%) more than the historical average

MEP Cristian Terhes, Dr. Robert Malone, MEP Christine Anderson, MEP Ivan Sincic MEP Mislav Kolakušić Original YT link, https://www.youtube.com/watch?v=anJWQ5eDfio International European Parliament covid summit part 1, https://www.youtube.com/watch?v=bFLPWWCAHfQ&t=11463s Part 2, https://www.youtube.com/watch?v=vJ93mW_sMPo&t=11321s

Poster and books, free download https://drjohncampbell.co.uk/ Article by Article Compilation of Proposed Amendments to the International Health Regulations (2005) https://apps.who.int/gb/wgihr/pdf_files/wgihr1/WGIHR_Compilation-en.pdf From video 9th May Article 1 Definitions “standing recommendation” means non-binding advice issued by WHO “temporary recommendation” means non-binding advice issued by WHO Article 2 Scope and purpose including through health systems readiness and resilience in ways that are commensurate with and restricted to public health risk all risks with a potential to impact public health, Article 3 Principles The implementation of these Regulations shall be with full respect for the dignity, human rights and fundamental freedoms of persons Article 10 Verification whilst encouraging the State Party to accept the offer of collaboration by WHO, taking into account the views of the State Party concerned. Article 11 Exchange of information WHO shall facilitate the exchange of information between States Parties and ensure that the Event Information Site For National IHR Focal Points offers a secure and reliable platform Article 12 Determination of a public health emergency of international concern public health emergency of regional concern, or intermediate health alert 2. If the Director-General considers, that a potential or actual public health emergency of international concern is occurring, If the Director-General determines that the event constitutes a public health emergency of international concern, and the State Party are in agreement regarding this determination, 5. If the Director-General, following consultations with the Emergency Committee and relevant States Parties the State Party within whose territory the public health emergency of international concern has occurred, New para 6: Where an event has not been determined to meet the criteria for a public health emergency of international concern, but the Director-General has determined it requires heightened international awareness and a potential international public health response, the Director-General, on the basis of information received, may determine at any time to issue an intermediate public health alert to States Parties Article 13 Public health response 3. At the request of a State Party, WHO shall collaborate clearly defined assistance to a State Party offer assistance to a State Party in the response to public health risks and other events by providing technical guidance, health products, technologies, know-how, deployment of civil medical personals, The State Party shall accept or reject such an offer of assistance within 48 hours and, in the case of rejection of such an offer, shall provide to WHO its rationale for the rejection, which WHO shall share with other States Parties. 4. If WHO, … determines that a public health emergency of international concern is occurring, it may shall offer, in addition to the support indicated in paragraph 3 of this Article, 5. When requested by WHO, States Parties should shall provide, to the extent possible, support to WHO- coordinated response activities, including supply of health products and technologies, especially diagnostics and other devices, personal protective equipment, therapeutics, and vaccines, for effective response to PHEIC occurring in another State Party’s jurisdiction and/or territory, NEW Article 13A WHO Led International Public Health Response States Parties recognize WHO as the guidance and coordinating authority of international public health response during public health Emergency of International Concern and undertake to follow WHO’s recommendations in their international public health response. New Article 13A: Access to Health Products, Technologies and Know-How for Public Health Response Immediately after the determination of a public health emergency of international concern under Article 12, the Director General shall make an immediate assessment of availability and affordability of required health products and make recommendations, including an allocation mechanism, 3. States Parties shall provide, in their intellectual property laws and related laws and regulations, exemptions and limitations to the exclusive rights of intellectual property holders to facilitate the manufacture, export and import of the required health products, including their materials and components. e) establish a repository for cell-lines to accelerate the production and regulatory of similar biotherapeutics products and vaccines NEW Chapter IV (Article 53 bis-quater): The Compliance Committee 53 bis Terms of reference and composition 1. The State Parties shall establish a Compliance Committee that shall be responsible for: New Article 54 bis – Implementation4] The Health Assembly shall be responsible to oversee and promote the effective implementation of these Regulations.

Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience https://pubmed.ncbi.nlm.nih.gov/30611908/ Dayton and Cincinnati, Ohio Vitamin D3 is a hormone produced in the skin, in amounts estimated up to 25,000 international units (IUs) a day, by the action of UVB radiation Vitamin D deficiency is common, lack of adequate sun exposure to the skin, vitamin D is present in very few food sources. Deficiency is strongly linked to increased risk for a multitude of diseases, several of which have historically been shown to improve dramatically with either adequate UVB exposure to the skin, or to oral supplementation with vitamin D. These diseases include Asthma, psoriasis, rheumatoid arthritis, rickets and tuberculosis. All patients in our hospital have been routinely screened on admission for vitamin D deficiency since July 2011 Offered supplementation to either correct or prevent deficiency We have admitted over 4,700 patients (vast majority agreed to supplementation) 5000 or 10,000 IUs/day. 125 micrograms or 250 micrograms Due to disease concerns, A few agreed to 20,000 to 50,000 IUs/day. 500 micrograms to 1, 250 micrograms (1.25mg) There have been no cases of vitamin D3 induced hypercalcemia, or any adverse events attributable to vitamin D3 Three patients with psoriasis Marked clinical improvement using 20,000 to 50,000 IUs/day Analysis of 418 inpatients on D3 Long enough to develop 25OHD3 blood levels > 74.4 ng/ml, showed a mean 25OHD3 level of 118.9 ng/ml (range from 74.4 to 384.8 ng/ml) Average serum calcium level in the vit D group of 418 9.6  mg/dl Range of 8.6 to 10.7 (Normal 8.5 to 10.5) Average serum calcium level in the non vit D group of 777 Mean 25OHD3 level of 27.1 ng/ml 9.5 mg/dl Range of 8.4 to 10.7 Parathyroid hormone levels A hormone released in response to low calcium levels D3 users, 24.2 pg/ml Non D3 users, 30.2 pg/ml In summary Long-term supplementation with vitamin D3 in doses ranging from 5000 to 50,000 IUs/day appears to be safe. Conclusion Daily oral intake of vitamin D3 ranging from 5000 IU/d to 60,000 IU/d for several years was well tolerated and safe, in both our patients and staff. The mean 25OHD blood levels in our patients appear to take around 12 months to plateau on 5000 IU/d and 10,000 IU/d. The average 25OHD values Patients taking 10,000 IU/d at 12 months = 96 ng/ml Then retested at 16 months = 97 ng/ml Currently considered upper limit of normal, 100 ng/ml Conflicts of Interest The authors have no conflicts of interest to disclose. Funding This research was performed without external funding.

'Brits are dying in their tens of thousands - and we don't really have any idea why' https://www.mirror.co.uk/news/health/brits-dying-tens-thousands-dont-29955386 Tens of thousands more Brits died than usual from May to December 2022, excluding Covid as a cause of death, raising serious questions as to why so many died May to December 2022, 32,441 excess deaths The number of deaths registered in the UK in the week ending 21 April 2023 (Week 16) Was 14,024 22.1% above the five-year average 2,540 excess deaths The number of deaths registered in the UK in the week ending 28 April 2023 https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending28april2023 (Week 17) Was 13,690 12.9% above the five-year average 1,569 excess deaths UK excess deaths in 2 weeks = 4,190 England and Wales 12,152 deaths 459 of these deaths mentioned novel coronavirus (3.8% of all deaths) Of the 459 deaths 65.6% (301 deaths) covid recorded as underlying cause The number of deaths was above the five-year average Private homes, 23.3% (646 excess deaths) Hospitals, 10.7% (521 excess deaths) Care homes, 8.4% (186 excess deaths) Other settings, 14.3% (117 excess deaths) Excess mortality in England and English regions: May 2023 update Latest update, 12th May, data to end of April 2023 https://www.gov.uk/government/statistics/announcements/excess-mortality-in-england-and-english-regions-may-2023-update https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

First three parent baby born in UK First British ‘3 parent baby’ Maternal spindle transfer repair is done before fertilisation Pronuclear transfer, repair is done after fertilisation https://www.theguardian.com/science/2015/feb/02/three-parent-babies-explained https://www.express.co.uk/news/science/1768481/three-parent-baby-mitochondrial-donation-treatment-uk Scientific and Ethical Issues in Mitochondrial Donation https://www.tandfonline.com/doi/full/10.1080/20502877.2018.1440725 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31868-3/fulltext Question 1. Is this an ethical form of zygote generation? Question 1.a. Is current IVF ethical? Question 2. Should reproduction he medicalised? Question 2.a. Is reproduction a right or a privilege / gift? Question 3. Are you happy with germ line alterations? Question 4. Will this change spread through human populations? Question 5. Are there any unforeseen consequences in future generations? Question 6. Could this technology be abused in the future or in other places?

Excess deaths, dramatic increase, week ending 21 April 2023 https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending21april2023 The number of deaths registered in the UK in the week ending 21 April 2023 (Week 16) Was 14,024 22.1% above the five-year average 2,540 excess deaths, of these deaths, 615 involved COVID-19 England and Wales Week 16, 12,420 deaths were registered in England and Wales 538 of these deaths mentioned novel coronavirus (4.3% of all deaths) Of the 538 deaths involving COVID-19, 66.5% (358 deaths) had this recorded as the underlying cause of death The number of deaths was above the five-year average Private homes (29.0% above, 771 excess deaths) Hospitals (20.2% above, 924 excess deaths) Care homes (25.3% above, 525 excess deaths) Other settings (11.7% above, 92 excess deaths) Could Bradford Hill criteria help? The larger the association, the more likely that it is causal. Consistent findings observed by different persons in different places Lack of alternative explanations The effect has to occur after the cause Greater exposure should generally lead to greater incidence of the effect. A plausible mechanism between cause and effect is helpful Coherence between epidemiological and laboratory findings increases the likelihood of an effect. Occasionally it is possible to appeal to experimental evidence Analogies or similarities between the observed association and any other associations. Sometimes, reversibility

Countries from around the world are currently working on negotiating and/or amending two international instruments, which will help the world be better prepared when the next event with pandemic potential strikes. The Intergovernmental Negotiating Body (INB) https://inb.who.int to draft and negotiate a convention, agreement or other international instrument to strengthen pandemic prevention, preparedness and response (commonly known as the Pandemic Accord). Amendments to the International Health Regulations https://www.who.int/teams/ihr/working-group-on-amendments-to-the-international-health-regulations-(2005) https://apps.who.int/gb/wgihr/pdf_files/wgihr1/WGIHR_Compilation-en.pdf to amend the current International Health Regulations (2005) https://apps.who.int/gb/wgihr/ https://www.who.int/publications/i/item/9789241580496 66 2005 articles Underlined and bold = proposal to add text Strikethrough = proposal to delete existing text (cut and paste does not copy strike through so I’ve put them in comic sans) Article 1 Definitions “standing recommendation” means non-binding advice issued by WHO “temporary recommendation” means non-binding advice issued by WHO Article 2 Scope and purpose including through health systems readiness and resilience in ways that are commensurate with and restricted to public health risk all risks with a potential to impact public health, Article 3 Principles The implementation of these Regulations shall be with full respect for the dignity, human rights and fundamental freedoms of persons Article 4 Responsible authorities each State Party should inform WHO about the establishment of its National Competent Authority responsible for overall implementation of the IHR that will be recognized and held accountable Article 5 Surveillance the State Party may request a further extension not exceeding two years from the Director-General, who shall make the decision refer the issue to World Health Assembly which will then take a decision on the same WHO shall collect information regarding events through its surveillance activities Article 6 Notification No sharing of genetic sequence data or information shall be required under these Regulations. Article 9: Other Reports Before taking any action based on such reports, WHO shall consult with and attempt to obtain verification from the State Party in whose territory the event is allegedly occurring Article 10 Verification whilst encouraging the State Party to accept the offer of collaboration by WHO, taking into account the views of the State Party concerned. Article 11 Exchange of information WHO shall facilitate the exchange of information between States Parties and ensure that the Event Information Site For National IHR Focal Points offers a secure and reliable platform Parties referred to in those provisions, shall not make this information generally available to other States Parties, until such time as when: (e) WHO determines it is necessary that such information be made available to other States Parties to make informed, timely risk assessments.

Supportive video from Dr. Dhand, https://www.youtube.com/watch?v=oaP5-CQP0wg&t=239s

Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response (Preprint) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987002/ https://www.science.org/doi/10.1126/sciadv.abi6110 Cannabidiol (CBD) Potential regulator of the host stress and antiviral inflammatory responses (cannabinoid class of natural products) Hemp, cannabis plants, Less than 0.3% psychotropic tetrahydrocannabinol (THC) Oral solution of CBD is a U.S. FDA approved drug High-purity CBD inhibits SARS-CoV-2 replication in human lung epithelial cells Pretreated human lung cells (with ACE2 receptor) for 2 hours with CBD before infection with SARS-CoV-2. CBD potently inhibited viral replication under nontoxic conditions (no toxicity was observed at the effective doses) Worked in other human lung cell lines, worked in monkey kidney cells Tested on Wuhan strain and 3 VOCs Their ability to infect cells was comparably inhibited by CBD CBD or other cannabinoids? Checked 97 to 100% pure using quantitative nuclear magnetic resonance (qNMR). No toxicity was observed for any of the CBD preparations at the doses used to inhibit viral infection The CBD metabolite 7-OH-CBD, 7-hydroxy-cannabidiol exhibits antiviral activity Others did not work Combining CBD with THC (1:1) significantly suppressed CBD efficacy, consistent with competitive inhibition by THC. CBD and 7-OH-CBD metabolite are the active and equipotent ingredients for the treatment of epilepsy CBD acts at an early step after viral entry into cells CBD targets host cell processes. CBD inhibits viral RNA expression and reverses viral-induced changes in host gene expression CBD effectively eradicated viral RNA expression in the host cells Prevents changes in the cell produced by the virus to force the cell to produce new viral particles CBD induces strong activation of genes associated with the host stress response. Together, these results suggest that CBD acts to prevent viral protein translation and associated cellular changes. Induction of viral genes for spike, envelope, and nucleocapsid proteins is reduced ~99% with CBD CBD induction of increased transcription of 3 defensive endoplasmic reticulum genes CBD induces interferon expression as part of its antiviral activity CBD suppress viral infection, and promote degradation of viral RNA (SARS-CoV-2 infection suppresses the interferon signaling pathway) CBD sufficiently lowers the effective viral titer to enable normal host activation of the interferon pathway. CBD effectively reversed viral induction of cytokines that can lead to deadly cytokine storm CBD treatment significantly inhibits SARS-CoV-2 replication in mice After viral the challenge, administration of CBD continued twice daily for an additional 4 days CBD treatment significantly inhibited viral replication in lungs and nasal turbinates at day 5 after infection Lower dose of CBD reduced viral load by 4.8-fold in lungs Higher dose of CBD reduced viral load by 40 -fold in lungs During this period, the mice showed no signs of clinical disease These results establish the preclinical efficacy of CBD as an antiviral drug for SARS-CoV-2 during early stages of infection. CBD is negatively associated with indications of SARS-CoV-2 infection in patient medical records Given that high-purity CBD preparations are taken by a large number of individuals, we examined whether CBD prescriptions are associated with indications of SARS-CoV-2 infection An oral solution of CBD (100 mg/ml) (CBD100) is often used for the treatment of seizures Analysis of 1,212 patients Matched to control group counterparts 6.2% (75 patients) with CDB 8.9% for non-CBD patients (P = 0.014) Odds ratio (OR) of 0.65, (P = 0.009) Odds ratio (OR) of 0.48, (P = 0.006) Potential of Cannabidiol for the Treatment of Viral Hepatitis https://scholar.google.com/scholar_lookup?title=Potential+of+cannabidiol+for+the+treatment+of+viral+hepatitis&author=H.+I.+Lowe&author=N.+J.+Toyang&author=W.+McLaughlin&publication_year=2017&journal=Pharm.+Res.&pages=116-118 CBD inhibited HCV replication by 86.4% (Not Hep B) Other RNA viral infections Common cold Influenza SARS / MERS Dengue Hep C and E Ebola Rabies Polio Mumps Measles

Free posters and books, https://drjohncampbell.co.uk Circulating vitamin D level and mortality in prostate cancer patients: a dose–response meta-analysis https://pubmed.ncbi.nlm.nih.gov/30352424/ Results Higher vitamin D level could reduce the risk of death among prostate cancer patients. Association of circulating 25-hydroxyvitamin D level with prognosis of prostate cancer We conducted a dose-response meta-analysis Seven eligible cohort studies, n = 7, 808 The summary HR of prostate cancer-specific mortality An increment of every 20 nmol/L in circulating vitamin D, (20 nmol/L = 8 ng/ml) HR = 0.91, (P = 0.002) Every 20 nmol/L increment in 25-hydroxyvitamin D level was associated with a 9% lower risk of, all-cause mortality, and prostate cancer-specific mortality. Pooled HRs were stable and not obviously changed by any single study. No evidence of publications bias was observed. This meta-analysis suggested that higher 25-hydroxyvitamin D level was associated with a reduction of mortality in prostate cancer patients, and vitamin D is an important protective factor in the progression and prognosis of prostate cancer. Risk estimates with 95% CI for the association between 25(OH)D and prostate cancer-specific mortality. Mechanism Vit D, could cause cell cycle arrest, and induce apoptosis, inhibiting cell proliferation in several prostate cancer cell lines Protection from prostate epithelial cell lines from oxidative stress Will supplements help? Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/33206192/ 4,000 units (100 micrograms) day 24 of 44 subjects (55%) showed a decrease in the number of positive cores or decrease in Gleason score Prostate cancer in black Americans https://aacrjournals.org/cancerrescommun/search-results?page=1&q=African%20American%20Prostate%20Cancer%20Displays%20Quantitatively%20Distinct%20Vitamin%20D%20Receptor&SearchSourceType=1 Cancer prevention https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/vitamin-d-fact-sheet Numerous epidemiologic studies have shown that higher intake or blood levels of vitamin D are associated with a reduced risk of colorectal cancer

With James Freeman on TNT radio, https://tntradio.live/presenters/james-freeman/ Direct link to the Freeman Report, https://tntradio.live/shows/the-freeman-report-with-james-freeman/ Today we discuss end of life care, euthanasia, informed consent, inaccurate freedom of information requests and the WHO wants more powers.

Lanarkshire Freedom of Information https://www.whatdotheyknow.com/request/962711/response/2295660/attach/html/3/Maternity%20statistics%20Wilkens%20March.doc.html I regret to advise that I am unable to provide you with details of the Covid-19 vaccination status for 2021 and 2022, as this information is not centrally recorded. To find this information would require a manual check of patient records. This information gathering would exceed the charging threshold prescribed in the Regulations https://www.ons.gov.uk/aboutus/transparencyandgovernance/freedomofinformationfoi/stillbirthsandmiscarriagesintheuk2022 Stillbirths and miscarriages in the UK 2022 16 December 2022, FOI Mortality statistics for England and Wales There were 2,597 stillbirths in 2021, an increase of 226 from 2020. We have not conducted analysis of stillbirths in 2022. This will be published as part of our Live Births release due in July 2023. We do hold stillbirth data up to June 22 (Quarter 2), therefore we can produce this as a bespoke data request. The analysis would be subject to legal frameworks, disclosure control, resources, and agreements of costs Miscarriages Unfortunately, we do not hold data relating to miscarriages. Therefore, this information is not held. Latest from Australia https://www.derbytelegraph.co.uk/news/health/rise-stillbirths-royal-derby-hospital-8368911 Latest from the US https://www.cdc.gov/ncbddd/stillbirth/data.html

With Mr. Danny Kruger M.P.

Symptom Prevalence (%) Sore throat 61.08 Blocked nose 56.58 Runny nose 53.77 Headache 50.17 Cough no phlegm 49.16 Sneezing 48.82 Cough with phlegm 40.83 Hoarse voice 38.58 Muscle pains aches 27.9 Altered smell 21.71 Dizzy light headed 21.26 Eye soreness 19.01 Swollen neck glands 18.79 Fatigue 18.45 Loss of smell 18.34 Earache 16.09 Chest pain tightness 13.95 Shortness of breath 13.27 Joint pain shoulders 12.6 Joint pain hips 11.25 ONS, finished 24th March 2023 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/deaths UK Prevalence https://health-study.joinzoe.com One in 60

Amendments to the International Health Regulations (2005) https://apps.who.int/gb/wgihr/ https://www.who.int/news-room/questions-and-answers/item/international-health-regulations-amendments https://www.who.int/news/item/25-02-2023-governments-hold-first-detailed-discussions-on-proposed-amendments-to-the-international-health-regulations-(2005) https://www.who.int/health-topics/international-health-regulations#tab=tab_1 WHO funding http://open.who.int/2020-21/contributors/contributor The WHO Pandemic Preparedness Treaty https://commonslibrary.parliament.uk/research-briefings/cbp-9550/ Download the full document WHO Member States agree to develop zero draft of legally binding pandemic accord in early 2023 https://www.who.int/news/item/07-12-2022-who-member-states-agree-to-develop-zero-draft-of-legally-binding-pandemic-accord-in-early-2023

AZ vaccine https://www.bbc.co.uk/news/uk-england-london-65321937 "unintended complications of the vaccine", an inquest has ruled. Dr. Stephen Wright, (south-east London), died 10 days after his first AZ dose in January 2021 London Inner South Coroner's Court, Senior coroner Andrew Harris found Mrs Charlotte Wright Trying to get the "natural causes" wording changed Brainstem infarction, cerebral haemorrhage, "vaccine-induced thrombosis" "It was made clear that Stephen was [previously] fit and healthy and that his death was by vaccination of AstraZeneca. For us, it allows us to be able to continue our litigation against AstraZeneca. This is the written proof." "Even with people in my life, there were questions and queries about whether I was actually telling the truth so, two years later, I can finally say it is the truth." "It provides relief but it doesn't provide closure. I think we're only going to get that when we have an answer from AstraZeneca and the government." Mrs Wright, received £120,000, government's Vaccine Damage Payment Scheme (VDPS) in August Up to 21 March 63 out of 4,178 claims paid From May 2021 AZ jab no longer offered to adults under 40 https://www.youtube.com/watch?v=FwLQVjETp64 BBC, Lisa Shaw had first vaccination in May 2021 Died a week later. Aged 44 https://www.independent.co.uk/news/health/lisa-shaw-astrazeneca-vaccine-death-bbc-b2318224. https://www.bbc.co.uk/news/uk-england-tyne-65187992 Questions Has the yellow card report been completed retrospectively? Death certification, (UK, May 2016) https://www.gov.uk/government/publications/changes-to-the-death-certification-process/an-overview-of-the-death-certification-reforms increase transparency for bereaved families improve the quality and accuracy of medical certificates of cause of death (MCCDs) introduce medical examiners to provide a system of effective medical scrutiny applicable to all deaths that do not require a coroner’s post-mortem or inquest enable medical examiners to report matters of a clinical governance nature to support local learning and changes to practice and procedures provide information on public health surveillance requested by a Director of Public Health Proportionate, independent and consistent scrutiny All medical certificates of cause of death (MCCDs) will be confirmed by local medical examiners. A system that learns from errors and poor practise Medical examiners will have powers to report matters of patient safety to the local clinical governance team for prompt action. This will improve safety in the NHS, allowing easier identification of trends and unusual patterns, and enable local learning and changes to practise and procedures.

Lab leak, US senate report https://www.telegraph.co.uk/world-news/2023/04/18/coronavirus-covid-origin-wuhan-lab-us-senate-report/ The 300-page report, released to Axios Pandemic, most likely "research-related incident" in Wuhan WIV may have begun developing two Covid vaccines in November 2019 "means SARS-CoV-2 would have been present at the WIV before the known outbreak of the pandemic." Theory that Covid-19 jumped from animals to humans in a market, no longer deserved "presumption of accuracy" Advocates of natural transmission theory, "must provide clear and convincing evidence" for their argument. "The preponderance of information affirms the plausibility of a research-related incident, that was likely unintentional resulting from failures of biosafety containment during vaccine-related research." Only one place, only one time “In short, human errors, mechanical failure, animal bites, animal escapes, inadequate training, insufficient funding, and pressure for results can lead to an escape of virulent pathogens, which could, in turn, infect animals and humans and lead to a release of a virus from a lab." Richard Burr report from last October https://www.help.senate.gov/imo/media/doc/report_an_analysis_of_the_origins_of_covid-19_102722.pdf FBI Director Christopher Wray (Feb 2023) "most likely" resulted from a potential lab leak in Wuhan Department of Energy Full 300 page document https://www.documentcloud.org/documents/23780776-mwg-fdr-document-04-16-23 MWG executive summary, April 16 2023 https://www.documentcloud.org/documents/23780771-mwg-executive-summary-april-16-2023 Epidemiology Favors (Early) Mid October-Early November Emergence China’s official position is that the COVID-19 outbreak began no earlier than December 8, 2019. An increase in adult Influenza-Like-Illness (ILI) accompanied by negative results, statistically significantly higher than reported in the previous 5 years Eyewitness accounts, media reports, epidemiological modeling and additional academic studies, car parking, internet searches October to November 2019 “By mid-October 2019, the dedicated team at the U.S. Consulate General in Wuhan knew that the city had been struck by what was thought to be an unusually vicious flu season. The disease worsened in November.” Several researchers inside the WIV became sick in autumn 2019, loss of smell and ground-glass opacities in his lungs Precedent of Zoonotic Spillovers & Likelihood of an Animal Origin Failed animal-to-human transmissions, or “dead-end” spillovers, typically leave behind serological evidence. It would be expected that environmental samples collected from wet markets that were positive for SARS-CoV-2 would likely show evidence of animal genetic adaptation. China CDC Analyzed 1,380 samples, environment (923) animals (457) 73 SARS-CoV-2 positive environmental samples. None of the samples taken from the 18 animal species found in the market were positive for SARS- CoV-2. The three live viruses were sequenced, 99.980% to 99.993% similarity with human isolates Unlike the 2003 SARS outbreak, H7N9 influenza, (China March 2013) Multiple independent viral introductions, time and place China, no infection or positive serological sample(s) of any susceptible animal prior to the recognized outbreak. Plausibility of a Research-related Incident & Laboratory-acquired infections Professor Yusen Zhou of the Academy of Military Medical Sciences (AMMS) filed a patent for a Covid-19 vaccine on February 24, 2020 “uncertainties” surrounding the death of Prof Zhou, (died spring 2020) Wuhan Institute of Virology (WIV) might have been selling laboratory animals for human consumption WIV, experimenting on palm civets (29 per month were sold at the 17 wet markets in Wuhan) (January 3, 2020, a professor at China Agricultural University in Beijing was sentenced for corruption, and for selling animals and animal products after laboratory experiments) Summation of Events Leading to the Pandemic EcoHealth Alliance with the WIV, Project DEFUSE: Defusing the Threat of Bat-borne Coronaviruses These experiments could create chimeric SARS-related viruses with Furin cleavage sites unknown in nature Wuhan scientists filed 13 patents to improve biosecurity in the six months before the pandemic E.g maintaining airtight seals on doors, ways of improving sterilisers and air filters Scientists were working with centrifuges that could have sprayed the virus into the air On November 19, 2019, Wuhan scientists were to attend mandatory biosecurity training Taught by official from the Chinese Academy of Sciences Session followed by remedial biosafety training course for WIV researchers Wuhan officials carried out an emergency airport drill on Sept 18, 2019, to identify passengers infected with novel coronavirus China’s National People’s Congress drafted legislation to strengthen the management of laboratories Pandemic may have been started by two spillover events, two weeks apart, minor genetic differences in early circulating strains, suggesting two lineages Mid-October to mid-November 2019 WIV collected 20,000 bat and animal samples by 2019, but did not disclose all of the viruses Before 2019, the WIV published sequences in a public database, taken offline in September 2019